RedHill Biopharma Balance Sheet Health
Financial Health criteria checks 5/6
RedHill Biopharma has a total shareholder equity of $2.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $23.0M and $21.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.57m |
| Equity | US$2.07m |
| Total liabilities | US$20.98m |
| Total assets | US$23.05m |
Recent financial health updates
Recent updates
RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks
Jul 28
One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts
Nov 24RedHill Biopharma receives Nasdaq notification regarding minimum bid price deficiency
Oct 18RedHill wins EU’s orphan drug status to RHB-204 for rare lung disease
Aug 17RedHill: Given Up For Dead
Apr 30RedHill Biopharma: Looking At An Unexciting Dead-End
Dec 30RedHill Biopharma Ltd. (NASDAQ:RDHL) Just Reported, And Analysts Assigned A US$15.79 Price Target
Dec 02Financial Position Analysis
Short Term Liabilities: RDHL's short term assets ($16.1M) do not cover its short term liabilities ($19.2M).
Long Term Liabilities: RDHL's short term assets ($16.1M) exceed its long term liabilities ($1.7M).
Debt to Equity History and Analysis
Debt Level: RDHL is debt free.
Reducing Debt: RDHL had no debt 5 years ago.
Debt Coverage: RDHL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: RDHL has no debt, therefore coverage of interest payments is not a concern.